best glp 1 companies biggest GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 brain cell function and reduce fatigue for those low in B12 TrimRX | Saxenda vs Ozempic:

LUPKIN: And that's on top of already-high insurance premiums

Injections are physical trauma

When Burping Signals a Need for Dose or Medication Adjustment While occasional burping is a normal, temporary side effect, persistent severe burping after 8 weeks may indicate your dose is advancing too quickly or your current medication formulation isn't ideal for your metabolism

However, GLP-1 receptor agonists like semaglutide and liraglutide may delay gastric emptying, which could theoretically affect the absorption of oral medications including levothyroxine

Ned Lamont proposed doing away with a 2023 requirement that Medicaid cover GLP-1s for severe obesity, though the state has never fully abided by the law due to the cost

Because of this, many GLP-1 users have experienced nutritional deficiencies, leading to additional health issues (4)